.Amgen has discussed (PDF) the initial period 3 records on its own $400 thousand dermatitis medicati...
.Biogen and also UCB's rely on improving right into period 3 on the back of an unsuccessful research...
.Italian biotech Aptadir Therapies has released along with the pledge that its own pipeline of precl...
.Surge Life Sciences has actually met its own target in a Duchenne muscle dystrophy (DMD) study, ins...
.After a few years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma layer, occup...
.Achilles Rehabs has shreded its own approach. The British biotech is quiting working on its clinica...
.Aligos Therapies is advertising a midstage gain in metabolic-dysfunction affiliated steatohepatitis...
.Basilea Pharmaceutica's job developing brand-new antifungals has acquired a substantial increase co...
.Having currently gathered up the USA liberties to Capricor Rehabs' late-stage Duchenne muscle dystr...
.After dismissing the choice meeting for Applied Therapies' metabolic disorder drug govorestat, the ...